Literature DB >> 6748160

Intracellular transport and secretion of hepatitis B surface antigen in mammalian cells.

E J Patzer, G R Nakamura, A Yaffe.   

Abstract

The oligosaccharide processing and secretion of hepatitis B surface antigen (HBsAg) was studied in Chinese hamster ovary cells stably transfected with the gene coding HBsAg. HBsAg was secreted from cells with a relatively long half time (ca. 5 h). This appeared to be a characteristic of HBsAg itself, since HBsAg-producing cells infected with vesicular stomatitis virus transported the viral envelope glycoprotein to the cell surface with normal kinetics (half time of ca. 30 min). The secreted HBsAg was comprised of both the unglycosylated (P20) and the glycosylated (G25) polypeptides, characteristic of HBsAg isolated from human serum or secreted from other cell lines (C. W. Crowley, C.-C. Liu, and A. D. Levinson, Mol. Cell. Biol. 3:44-55, 1983; M. F. Dubois, C. Pourcel, S. Rousset, C. Chang, and P. Tiollais, Proc. Natl. Acad. Sci. U.S.A. 77:4549-4553, 1980; C.-C. Liu, D. Yansura, and A. D. Levinson, DNA, 1:213-221, 1982; G. M. Macnab, J. J. Alexander, G. Lecatsas, E. M. Bey, and J. M. Urbanocvicz, Br. J. Cancer, 24:509-515, 1976; A. M. Moriarity, B. H. Hoyer, J. W.-K. Shih, J. L. Gerin, and D. H. Hamer, Proc. Natl. Acad. Sci. U.S.A. 78:2606-2610, 1981; D. L. Peterson, J. Biol. Chem., 256:6975-6983, 1981). The glycosylated polypeptide (GP25) contained complex oligosaccharide chains. Cell-associated HBsAg also was comprised of both an unglycosylated and a glycosylated polypeptide; however, the glycosylated form (GP23) contained only high-mannose oligosaccharide chains. No oligosaccharide processing of the high-mannose chains could be detected within the cells. Thus, most of the time before secretion of HBsAg from cells must have been spent in a pre-Golgi or early Golgi compartment. Glycosylation was inhibited completely by tunicamycin, although unglycosylated particles were still secreted from cells and were antigenic. The secretion and oligosaccharide processing of HBsAg were inhibited with high concentrations of monensin, but at lower concentrations of monensin HBsAg was still secreted, although only half of the oligosaccharide chains were processed to the complex form.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6748160      PMCID: PMC254444          DOI: 10.1128/JVI.51.2.346-353.1984

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Localization of two cellular forms of the vesicular stomatitis viral glycoprotein.

Authors:  D M Knipe; H F Lodish; D Baltimore
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

2.  Synthesis and processing of human chorionic gonadotropin subunits in cultured choriocarcinoma cells.

Authors:  R W Ruddon; C A Hanson; N J Addison
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

3.  Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-phosphate Glc-NAc-1-phosphate transferase.

Authors:  A Heifetz; R W Keenan; A D Elbein
Journal:  Biochemistry       Date:  1979-05-29       Impact factor: 3.162

4.  An ultrastructural study of liver explants from infants with vertically transmitted hepatitis.

Authors:  A E Dunn; R L Peters; I L Schweitzer
Journal:  Exp Mol Pathol       Date:  1973-08       Impact factor: 3.362

5.  Electron microscopic observations and speculations on Australia antigen.

Authors:  J D Almeida
Journal:  Postgrad Med J       Date:  1971-07       Impact factor: 2.401

6.  Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis.

Authors:  A Alberti; G Realdi; F Tremolada; G P Spina
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

7.  Letter: HBsAg on cell membrane in symptom-free carrier.

Authors:  S Furuta; K Kiyosawa; A Nagata; Y Akahane; M Oda
Journal:  Lancet       Date:  1975-08-02       Impact factor: 79.321

Review 8.  Hepatitis B. Cytologic localization of virus antigens and the role of the immune response.

Authors:  G Yamada; L E Feinberg; P K Nakane
Journal:  Hum Pathol       Date:  1978-01       Impact factor: 3.466

9.  Hepatoma secretory proteins migrate from rough endoplasmic reticulum to Golgi at characteristic rates.

Authors:  H F Lodish; N Kong; M Snider; G J Strous
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

10.  Hepatitis B surface antigen produced by a human hepatoma cell line.

Authors:  G M MacNab; J J Alexander; G Lecatsas; E M Bey; J M Urbanowicz
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

View more
  36 in total

1.  Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles.

Authors:  R Prange; R Nagel; R E Streeck
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  Mutational analysis of hepatitis B surface antigen particle assembly and secretion.

Authors:  V Bruss; D Ganem
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 3.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

4.  Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum.

Authors:  K Kuroki; R Russnak; D Ganem
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

Review 5.  Plant-derived virus-like particles as vaccines.

Authors:  Qiang Chen; Huafang Lai
Journal:  Hum Vaccin Immunother       Date:  2012-09-20       Impact factor: 3.452

6.  Distinctive properties of the hepatitis B virus envelope proteins.

Authors:  K L Molnar-Kimber; V Jarocki-Witek; S K Dheer; S K Vernon; A J Conley; A R Davis; P P Hung
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

7.  Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice.

Authors:  F V Chisari; P Filippi; A McLachlan; D R Milich; M Riggs; S Lee; R D Palmiter; C A Pinkert; R L Brinster
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

8.  A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion.

Authors:  Anne Marie Dougherty; Haitao Guo; Gael Westby; Yuanjie Liu; Ender Simsek; Ju-Tao Guo; Anand Mehta; Pamela Norton; Baohua Gu; Timothy Block; Andrea Cuconati
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

9.  Role of transmembrane domains of hepatitis B virus small surface proteins in subviral-particle biogenesis.

Authors:  Vera D Siegler; Volker Bruss
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

10.  Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein.

Authors:  C M Mangold; R E Streeck
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.